Bronchial hyperresponsiveness and asthma in the paediatric population

F Muñoz-López1

  • 1Pediatric Immunoallergology Center, Former Head of the Department of Pediatric Immunoallergology, Clínic Hospital - Sant Joan de Déu Hospital, Faculty of Medicine, University of Barcelona.

Insights

The intensity of bronchial hyperresponsiveness (BHR) did not correlate with patient age, IgE levels, or family history in children with asthma. Therefore, BHR intensity is not a reliable indicator for predicting asthma prognosis or phenotype.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Bronchial hyperresponsiveness (BHR) is a key feature of asthma.
  • Understanding factors influencing BHR intensity is crucial for asthma management and prognosis.
  • Previous studies have explored correlations between BHR and various clinical parameters.

Purpose of the Study:

  • To investigate the correlation between BHR intensity and clinical data in pediatric asthma patients.
  • To assess the potential of BHR intensity in establishing asthma prognosis or phenotype.
  • To examine the relationship between BHR, age at onset, serum IgE, and familial atopic history.

Main Methods:

  • Methacholine provocation test used to evaluate BHR in 138 children and adolescents (up to 18 years).
  • Patients categorized into six groups based on methacholine required for PD20.
  • Analysis included comparison between patients with and without a family history of atopic disease.

Main Results:

  • No significant differences in age at asthma onset or serum IgE levels were observed across varying BHR intensities.
  • No significant differences were found in these parameters between patients with and without a family history of atopic disease.
  • The study found no correlation between BHR intensity and the examined clinical or genetic factors.

Conclusions:

  • BHR intensity is not a valid parameter for establishing a prognosis or phenotype in pediatric asthma.
  • BHR intensity can, however, be utilized as a measure of asthma severity.
  • Further research may be needed to identify other reliable prognostic markers for pediatric asthma.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...